| Source publication date | |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Medical and professional news |
| Population | Men and women |
| Source | The DO (American Osteopathic Association) |
| URL | thedo.osteopathic.org/2026/03/rising-testosterone-use-among-youth (opens in a new tab) |
Specific Claim Evaluated
TRAVERSE studied older men with cardiovascular disease, and its findings cannot be applied to younger, healthy individuals using testosterone without medical indication.
Primary Research Supporting or Contradicting the Claim
TRAVERSE enrolled men aged 45 to 80 years with hypogonadism and preexisting or high cardiovascular risk (Lincoff et al., 2023). Former users of anabolic-androgenic steroids can have persistent low testosterone years after stopping (Rasmussen et al., 2016).
Corrected Evidence-Based Interpretation
The article is correct.
Rationale for Grade
The authors correctly limit the trial population, describe suppression of the hypothalamic-pituitary-gonadal axis and recommend harm reduction monitoring. No claim overstates the evidence.
References
- Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. PMID
Supporting excerpt: "noninferior to placebo with respect to the incidence of major adverse cardiac events" - Rasmussen JJ, Selmer C, Østergren PB, Pedersen KB, Schou M, Gustafsson F, Faber J, Juul A, Kistorp C. Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: a case-control study. PLoS One. 2016;11(8):e0161208. PMID
Supporting excerpt: "Former AAS abusers exhibited significantly lower plasma testosterone levels"